Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|March 7, 2014
Medication Adherence Services
Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, talks about Diplomat's adherence program.
Advertisement
Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, talks about Diplomat's adherence program.
This video was shot at the 2013 Academy of Managed Care Pharmacy Nexus Meeting in San Antonio, Texas.
Advertisement
Related to this article
With changes in Medicaid eligibility looming, hospitals must plan now to keep patient care gaps at bay.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Community Pharmacy Must Pair Trust With Digital Convenience
5